Permanente gastroenterologist and researcher Douglas Corley, MD, commented in an NPR report about a recent study that cast doubts on the effectiveness of the procedure used to detect colon cancer
Kaiser Permanente study published in the journal Gastroenterology supports starting screening at age 45 among this higher-risk population.
People with gastroenterological symptoms are not being tested for COVID-19, perhaps allowing numerous cases to go undetected, Douglas A. Corley, MD, PhD, of The Permanente Medical Group (TPMG), told Science magazine.
Kaiser Permanente receives a $7 million grant to develop a better system to capture family risk of cancer.
Douglas Corley, MD, PhD, takes on a new role to lead delivery science program for optimizing care and treatment in Kaiser Permanente Northern California.